» Articles » PMID: 26875830

Harnessing the Plasticity of CD4(+) T Cells to Treat Immune-mediated Disease

Overview
Journal Nat Rev Immunol
Date 2016 Feb 16
PMID 26875830
Citations 258
Authors
Affiliations
Soon will be listed here.
Abstract

CD4(+) T cells differentiate and acquire distinct functions to combat specific pathogens but can also adapt their functions in response to changing circumstances. Although this phenotypic plasticity can be potentially deleterious, driving immune pathology, it also provides important benefits that have led to its evolutionary preservation. Here, we review CD4(+) T cell plasticity by examining the molecular mechanisms that regulate it - from the extracellular cues that initiate and drive cells towards varying phenotypes, to the cytosolic signalling cascades that decipher these cues and transmit them into the cell and to the nucleus, where these signals imprint specific gene expression programmes. By understanding how this functional flexibility is achieved, we may open doors to new therapeutic approaches that harness this property of T cells.

Citing Articles

Palmoplantar Pustulosis as an Immune-Mediated Inflammatory Disease with a Possible Relevance of Th17 Cell Plasticity: A Narrative Review.

Terui T, Murakami M, Okubo Y, Hayama K, Fujita H Dermatol Ther (Heidelb). 2025; .

PMID: 40088419 DOI: 10.1007/s13555-025-01382-6.


-specific TIGIT Treg are present in the blood of healthy subjects - a hurdle for vaccination?.

Clegg J, Mnich M, Carignano A, Cova G, Tavarini S, Sammicheli C Front Immunol. 2025; 15:1500696.

PMID: 39981298 PMC: 11840346. DOI: 10.3389/fimmu.2024.1500696.


Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation.

Pashkina E, Blinova E, Bykova M, Aktanova A, Denisova V Cells. 2025; 13(24.

PMID: 39768148 PMC: 11675046. DOI: 10.3390/cells13242056.


A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response.

Feng B, Tang L Clin Transl Med. 2024; 15(1):e70154.

PMID: 39739593 PMC: 11686334. DOI: 10.1002/ctm2.70154.


High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.

Cochrane R, Robino R, Granger B, Allen E, Vaena S, Romeo M Mol Ther Methods Clin Dev. 2024; 32(4):101385.

PMID: 39687729 PMC: 11647616. DOI: 10.1016/j.omtm.2024.101385.


References
1.
Miller S, Huang A, Miazgowicz M, Brassil M, Weinmann A . Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression. Genes Dev. 2008; 22(21):2980-93. PMC: 2577798. DOI: 10.1101/gad.1689708. View

2.
Liu B, Tahk S, Yee K, Fan G, Shuai K . The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science. 2010; 330(6003):521-5. PMC: 3043201. DOI: 10.1126/science.1193787. View

3.
Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

4.
Zhou L, Lopes J, Chong M, Ivanov I, Min R, Victora G . TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008; 453(7192):236-40. PMC: 2597437. DOI: 10.1038/nature06878. View

5.
Park B, Pan F . The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases. Cell Mol Immunol. 2015; 12(5):533-42. PMC: 4579653. DOI: 10.1038/cmi.2015.21. View